Transcriptional profiling to identify a program of enzalutamide extreme non-response in lethal prostate cancer.

Anbarasu Kumaraswamy, Ya-Mei Hu, Joel Yates, Chao Zhang, Shangyuan Ye, Charles J. Ryan, David Quigley, Rahul Raj Aggarwal, Robert Evan Reiter, Tomasz M. Beer, Matthew Rettig, Martin Gleave, Primo N. Lara, Josh Stuart, George V. Thomas, Felix Y. Feng, Eric J. Small, Zheng Xia, Joshi J. Alumkal